From Blood Vessels to Mighty Mites: What’s Hot (and maybe not) in Dermatology Right Now

Small vessel vasculitis management relies on identifying systemic involvement through clinical indicators like nausea, vomiting, abdominal pain, and significant hematuria, while recent antibiotic use inversely correlates with systemic disease. GLP-1 receptor agonists present various dermatologic side effects, including injection site reactions, hair loss, and rare reports of dysesthesia, though their long-term impact on skin health remains under investigation. Intralesional triamcinolone acetonide at 2.5 mg/mL remains the optimal concentration for alopecia areata, balancing efficacy with atrophy risks. Hydrocolloid dressings offer superior patient comfort and convenience for surgical wound care compared to petrolatum, despite higher rates of minor bleeding and dehiscence. Furthermore, gene expression profiling for melanoma sentinel node status shows promise in risk stratification, though it currently falls short of providing a definitive threshold for safely omitting sentinel node biopsies in high-risk patients.